Status:
COMPLETED
CT Perfusion (CTP) for Assessment of Poor Neurological Outcome in Comatose Cardiac Arrest Patients
Lead Sponsor:
University of Manitoba
Collaborating Sponsors:
Manitoba Medical Service Foundation
Conditions:
Cardiac Arrest
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
ABSTRACT Brief Overview: Neurological assessment of comatose cardiac arrest patients (CCAP) is challenging because most of these patients are treated with sedatives and therapeutic hypothermia that p...
Detailed Description
This study will be conducted in our tertiary care cardiac center. The cohort will consist of newly admitted comatose adults (\>18 years of age) who have suffered an OHCA and are treated with standard ...
Eligibility Criteria
Inclusion
- Newly admitted comatose adults (≥18 years old) who have suffered an Out of Hospital Cardiac Arrest (OHCA)
- Treating physicians plan on instituting post cardiac arrest Targeted Temperature Management (TTM) therapies
Exclusion
- No substitute decision maker available for consent
- Known pregnancy
- Known contraindication to CT contrast agent, such as a history of allergy or anaphylactic reaction
- Known chronic kidney disease, stage 4-5 (eGFR \< 30 mL/min/1.73 m2)
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT04323020
Start Date
May 1 2021
End Date
December 31 2023
Last Update
January 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Boniface Hospital
Winnipeg, Manitoba, Canada, R2H 2A6